Latest From Biotech Now

World Diabetes Day: Get the Facts

logo

Today, November 14, is World Diabetes Day and advocacy organizations around the world are focused on raising awareness for prevention and treatment options. How prevalent is diabetes? According to the 2011 National Diabetes Fact Sheet, there are more than 25 million children and adults in the U.S. with diabetes, which includes more than 18 million people who have been diagnosed and an estimated seven million people who have not yet been diagnosed. Nearly 80 million Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

The Good, the Bad, and the Ugly for Biotech IPOs

2012-11-12-Technology-vs-HC-IPOs-btn

The troubles in the biotech IPO market are complicated to explain to industry outsiders. They read about new biotechs debuting on the public market, but also hear bankers, VCs, and CEOs complaining about how the IPO window never really opened after 2008. The reality is that we are seeing positive developments and negative trends simultaneously. On the bright side, the cumulative number of IPOs is holding up. The recent pace of biotech IPOs mimics what Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,

Labeling Foes: Fight if You Want, But We’ve Got to Feed the World

Karen-Batra-Feature

There were still millions of votes left to be counted in California when advocates for biotech labeling admitted defeat, but vowed to rise from the ashes and take their fight to the national level. Twenty-four hours had barely gone by when the New York Times, LA Times, San Francisco Chronicle and Sacramento Bee – among others – were reporting that biotech opponents still wanted to fight. The Yes on 37 campaign accused our side of using “dirty money Read More >

Farmer Gene  |  2 Comments  |  Email This Post
Tags: , , , , , , , , , , , , ,

When it Comes to Patients, There is No Average

average

Next month, the National Pharmaceutical Council will host a forum — which BIO is cosponsoring — that will focus on the unique differences among treatment effects in individual patients and how policymakers, payers, and providers could shape programs and policies to acknowledge those differences. The forum, “The Myth of Average:  Why Individual Patient Differences Matter” is taking place on November 30 at the Omni Shoreham Hotel in Washington, D.C. More information and registration materials are available Read More >

Events  |  Leave a comment  |  Email This Post

Academics to be Featured at the 2013 BIO Alliance Pavilion

BIO International Convention

I think it safe to say that the U.S. biotechnology industry has its R&D roots in the laboratories of great research universities with great science and visionary researchers. These cutting-edge, biology-based research and industry commercialization efforts continue to be the key drivers in moving invention into innovation to heal, fuel and feed the world. Because of this essential knowledge-driven relationship, the 2013 BIO International Convention will again bring together academic and research colleagues to focus Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,